Vaxart, Inc. (VXRT)
0.486
-0.01
(-2.78%)
USD |
OTCM |
Sep 18, 16:00
Vaxart 1 Year Total Returns (Daily) : 26.23% for Sept. 18, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 18, 2026 | 26.23% |
| September 17, 2026 | 28.84% |
| September 16, 2026 | 21.54% |
| September 15, 2026 | 30.93% |
| September 14, 2026 | 25.64% |
| September 11, 2026 | 24.39% |
| September 10, 2026 | 28.17% |
| September 09, 2026 | 28.52% |
| September 08, 2026 | 30.83% |
| September 04, 2026 | 31.40% |
| September 03, 2026 | 27.92% |
| September 02, 2026 | 29.59% |
| September 01, 2026 | 26.41% |
| August 31, 2026 | 30.77% |
| August 28, 2026 | 39.35% |
| August 27, 2026 | 35.37% |
| August 26, 2026 | 41.47% |
| August 25, 2026 | 42.27% |
| August 24, 2026 | 44.24% |
| August 21, 2026 | 44.26% |
| August 20, 2026 | 43.37% |
| August 19, 2026 | 35.45% |
| August 18, 2026 | 35.79% |
| August 17, 2026 | 34.97% |
| August 14, 2026 | 50.97% |
| Date | Value |
|---|---|
| August 13, 2026 | 51.60% |
| August 12, 2026 | 47.32% |
| August 11, 2026 | 50.91% |
| August 10, 2026 | 51.32% |
| August 07, 2026 | 40.95% |
| August 06, 2026 | 42.50% |
| August 05, 2026 | 60.19% |
| August 04, 2026 | 62.21% |
| August 03, 2026 | 65.83% |
| July 31, 2026 | 45.95% |
| July 30, 2026 | 44.39% |
| July 29, 2026 | 21.00% |
| July 28, 2026 | 19.01% |
| July 27, 2026 | 12.52% |
| July 24, 2026 | 21.32% |
| July 23, 2026 | 18.93% |
| July 22, 2026 | 18.02% |
| July 21, 2026 | 18.44% |
| July 20, 2026 | 13.46% |
| July 17, 2026 | 27.19% |
| July 16, 2026 | 29.59% |
| July 15, 2026 | 42.05% |
| July 14, 2026 | 27.91% |
| July 13, 2026 | 21.05% |
| July 10, 2026 | 57.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 72.53% |
| Amgen, Inc. | 43.68% |
| Anika Therapeutics, Inc. | 132.8% |
| BioCryst Pharmaceuticals, Inc. | 9.05% |
| Imunon, Inc. | -73.33% |